ASSOCIATION BETWEEN A HETEROCYCLIC COMPOUND STIMULATING LIPID AND CARBOHYDRATE METABOLISMS AND AN ANTIOXIDANT AGENT FOR TREATING OBESITY

Details for Australian Patent Application No. 2003288309 (hide)

Owner LES LABORATOIRES SERVIER

Inventors Dacquet, Catherine; Casteilla, Louis; Renard, Pierre; Berthelot, Pascal; Penicaud, Luc

Agent Watermark

Pub. Number AU-A-2003288309

PCT Number PCT/FR2003/0029

PCT Pub. Number WO2004/032968

Priority 02/12648 11.10.02 FR

Filing date 10 October 2003

Wipo publication date 4 May 2004

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/42 - Oxazoles

A61K 031/425 - Thiazoles

A61K 031/122 - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 031/355

A61P 003/04 Drugs for disorders of the metabolism

A61P 003/10 Drugs for disorders of the metabolism

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 02/12648 11.10.02 FR

3 June 2004 Application Open to Public Inspection

  Published as AU-A-2003288309

24 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003288310-DEVICE FOR CONNECTION BETWEEN A CORPOREAL DUCT AND A PROSTHESIS

2003288308-DRY ORAL PHLEBOTONIC AND VASCULOPROTECTIVE FORMULATION FOR THE TREATMENT OF VENOUS INSUFFICIENCY, CAPILLARY FRAGILITY AND HAEMORRHOIDS, IN THE PHARMACEUTICAL FORM OF A CHEWABLE TABLET CONTAINING DIOSMIN